Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2025-12-24 @ 8:03 PM
NCT ID:
NCT06692504
Eligibility Criteria:
Inclusion Criteria:
* Age ≥18 years
* Admission to adult emergency department of Besançon University Hospital
* Study period: January 1, 2018 to December 31, 2019
* Current oral anticoagulation therapy with:
* Acenocoumarol
* Apixaban
* Dabigatran
* Fluindione
* Rivaroxaban
* Warfarin
Exclusion Criterion:
\- Discontinuation of anticoagulant therapy for more than 24 hours
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06692504
Study Brief:
Protocol Section:
NCT06692504